Efficacy and Safety of Transarterial Chemoembolization in Elderly Patients of Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Study

Efficacy and Safety of Transarterial Chemoembolization in Elderly Patients of Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Study

ObjectiveThe aim of the current study was to evaluate the safety and efficacy of transcatheter arterial chemoembolization (TACE) in elderly patients diagnosed as advanced hepatocellular carcinoma (HCC) accompanied with different types of portal vein tumor thrombosis (PVTT).MethodsElderly HCC patient...

Full description

Bibliographic Details
Main Authors:	Qinghe Tang, Wei Huang, Jun Liang, Junli Xue
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Oncology
Subjects:	TACE elderly patients advanced HCC PVTT adverse event
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.646410/full

Similar Items

Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients
by: Jing-huan Li, et al.
Published: (2021-08-01)

Transradial approach for transarterial chemoembolization of hepatocellular carcinoma in Egyptian patients: Initial study
by: Mohamed El-Gharib, et al.
Published: (2016-09-01)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2017-07-01)

Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers
by: Christine Koch, et al.
Published: (2021-04-01)

MicroRNA signatures as predictive biomarkers in transarterial chemoembolization‐treated hepatocellular carcinoma
by: Manal S. Fawzy, et al.
Published: (2021-03-01)

Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
by: Maria Tampaki, et al.
Published: (2020-01-01)

FDG-avid portal vein tumor thrombosis from hepatocellular carcinoma in contrast-enhanced FDG PET/CT
by: Canh Nguyen, et al.
Published: (2015-01-01)

FDG-avid portal vein tumor thrombosis from hepatocellular carcinoma in contrast-enhanced FDG PET/CT
by: Canh Nguyen, et al.
Published: (2015-01-01)

Efficacy and Safety of SBRT Combined With Camrelizumab and Apatinib in HCC Patients With PVTT: Study Protocol of a Randomized Controlled Trial
by: Yue Hu, et al.
Published: (2020-08-01)

Transarterial Chemoembolization in Hepatocellular Carcinoma: A Clinical Efficacy Study of Ganoderma Lucidum Extract Polysaccharide Peptide β-Glucan
by: Bagaswoto Poedjomartono, et al.
Published: (2020-04-01)

Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE)
by: Xiaonan Mao, et al.
Published: (2021-08-01)

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies
by: Sven H. Loosen, et al.
Published: (2019-10-01)

Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
by: Lei Zhang, et al.
Published: (2021-08-01)

Role of 18-FDG/PET in evaluation of hepatocellular carcinoma managed locally by transarterial chemoembolization compared to triphasic computed tomography
by: Manal Ibraheim Gomaa
Published: (2020-07-01)

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads
by: Chang WC, et al.
Published: (2021-08-01)

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
by: Jang JH, et al.
Published: (2015-09-01)

Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients
by: Guan-Hui Zhou, et al.
Published: (2018-06-01)

The role of functional imaging; DWI, ADC and 18F-FDG PET/CT in the evaluation of HCC treatment response after transarterial chemoembolization
by: Ahmed S. Abdelrahman, et al.
Published: (2021-08-01)

Role of PET CT in comparison to triphasic CT in early follow-up of hepatocellular carcinoma after transarterial chemoemoblization
by: Waleed M. Hetta, et al.
Published: (2020-02-01)

Subtraction MRI versus diffusion weighted imaging: Which is more accurate in assessment of hepatocellular carcinoma after Trans Arterial Chemoembolization (TACE)?
by: Noha Abd ElShafy ElSaid, et al.
Published: (2016-12-01)

Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study
by: Asahiro Morishita, et al.
Published: (2021-09-01)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2020-08-01)

The value of dynamic subtraction MRI technique in the assessment of treatment response of hepatocellular carcinoma to transcatheter arterial chemoembolization
by: Lamiaa I. A. Metwally, et al.
Published: (2019-09-01)

Lipiodol retention pattern predicts transarterial chemoembolization therapeutic effect in hepatocellular carcinoma
by: Margaretha Vianny, et al.
Published: (2015-04-01)

Lipiodol retention pattern predicts transarterial chemoembolization therapeutic effect in hepatocellular carcinoma
by: Margaretha Vianny, et al.
Published: (2016-02-01)

Role of diffusion-weighted magnetic resonance imaging in the evaluation of hepatocellular carcinoma response to transcatheter arterial chemoembolization using drug eluting beads; correlation with dynamic MRI
by: Mohamed I. Yousef, et al.
Published: (2017-12-01)

Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm
by: Yashwant Patidar, et al.
Published: (2019-01-01)

EFFICACY OF INTRA-ARTERIAL LIDOCAINE FOR PAIN CONTROL RESULTING FROM TRANSARTERIAL CHEMOEMBOLIZATION OF HEPATOCELLULAR CARCINOMA
by: Ghulam Abbas, et al.
Published: (2021-06-01)

Utility of diffusion weighted imaging with the quantitative apparent diffusion coefficient in diagnosing residual or recurrent hepatocellular carcinoma after transarterial chemoembolization: a meta-analysis
by: Zhao Liu, et al.
Published: (2020-01-01)

Network meta-analysis of treatment regimens for inoperable advanced hepatocellular carcinoma with portal vein invasion
by: Li MF, et al.
Published: (2018-07-01)

Intra-arterial chemoembolization with hepasphere 50–100 μm for patients with unresectable hepatocellular
by: Talal Amer, et al.
Published: (2015-12-01)

Feasibility of Automated Volumetric Assessment of Large Hepatocellular Carcinomas' Responses to Transarterial Chemoembolization
by: Ahmed W. Moawad, et al.
Published: (2020-05-01)

PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
by: Sean P. Martin, et al.
Published: (2020-06-01)

Intermediate stage hepatocellular carcinoma: a summary review
by: Elshaarawy O, et al.
Published: (2019-07-01)

Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization
by: Naoshi Odagiri, et al.
Published: (2020-07-01)

A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization
by: Chang Liu, et al.
Published: (2018-02-01)

Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary
by: Aktas G, et al.
Published: (2018-04-01)

CT perfusion in hepatocellular carcinoma: Is it reliable?
by: Mennatallah Hatem Shalaby, et al.
Published: (2017-12-01)

CT-Guided 125I Brachytherapy in the Treatment of Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization: A Pilot Study
by: Xu X, et al.
Published: (2021-04-01)

TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01)